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ABSTRACT 
 
n-3 Polyunsaturated Fatty Acids Suppress Mitochondrial Translocation to the 
Immunological Synapse and Modulate Calcium Signaling in T Cells. (December 2010) 
Rajeshwari Yog, B.S., Texas Southern University 
Co-Chairs of Advisory Committee: Dr. Robert S. Chapkin  
 Dr. David N. McMurray 
 
T helper (Th) cell activation is necessary for the adaptive immune response.  
Formation of an immunological synapse (IS) between Th cells and antigen-presenting 
cells is the first step in Th cell activation.  In vitro studies indicate that formation of the 
IS induces cytoskeleton-dependent mitochondrial redistribution to the immediate 
vicinity of the IS.  This redistribution of mitochondria to the IS in T cells is necessary to 
maintain Ca2+ influx across the plasma membrane and Ca2+-dependent Th cell activation. 
Earlier studies have demonstrated that n-3 polyunsaturated fatty acids (PUFA) suppress 
the localization and activation of signaling proteins at the IS.  Therefore, we 
hypothesized that n-3 PUFA suppress CD4+ T cell mitochondrial translocation during 
the early stages of IS formation and down-modulate Ca2+ dependent Th cell activation.  
CD4+ cells derived from fat-1 mice, a transgenic model that synthesizes n-3 PUFA from 
n-6 PUFA, were co-cultured with anti-CD3-expressing hybridoma cells (145-2C11) for 
15 min at 37°C, and mitochondrial translocation to the IS was assessed by confocal 
microscopy.  fat-1 mice exhibited a significantly (P< 0.05) reduced percentage of CD4+ 
T cells with mitochondria which translocated to the IS; fat-1 (30%) versus wild type 
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control (82%).  With respect to an effect on the mitochondrial-to-cytosolic Ca2+ ratio, 
wild type cells showed significant increases at the IS (71%) and total cell (60%) within 
30 min of IS formation.  In contrast, fat-1 CD4+ T cells remained at basal levels 
following the IS formation.  A similar blunting of the mitochondrial-to-cytosolic Ca2+ 
ratio was observed in wild type cells co-incubated with inhibitors of the mitochondrial 
uniporter, RU360 or calcium release-activated Ca2+ (CRAC) channels, BTP2. Together, 
these observations provide evidence that n-3 PUFA modulate Th cell activation by 
limiting mitochondrial translocation to the IS and reducing Ca2+ entry.        
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW* 
 
 
 
 T cell activation requires contact with antigen-presenting cells (APCs) to bring 
the T cell receptor (TCR) and major histocompatibility complex (MHC)-peptide 
complex together.  In general, contact is defined by the size of the TCR and MHC-
peptide complex which, at approximately 10-15 nm, requires extensive interdigitation of 
the plasma membrane of the T cell and APC.  T cells are typically activated via 
formation of a stable T cell-APC junction, referred to as an immunological synapse (IS) 3 
(1-4). 
 When the T cell receptor is activated by antigen presentation, mitochondria 
redistribute close to the site of the IS, where they promote influx of Ca2+ (5).  The actin 
cytoskeleton-based recruitment of mitochondria in the vicinity of active synapses is 
required for Ca2+ influx through calcium release-activated calcium (CRAC) channels and 
activation of key downstream transcription factors such as NFAT. The translocation of 
the mitochondria to the IS is typically observed within 15 min after focal TCR cross-
linking (5) with a sustained peak around 30 min (6). Reduction in the T cell Ca2+ 
concentration close to the channel serves as a feedback inhibitory mechanism 
responsible for adjusting channel activity (5). Any agent which inhibits the movement of  
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mitochondria to the IS and modulates intracellular Ca2+ homeostasis can, therefore, 
prevent sustained IS formation, thereby suppressing T cell activation and function. A 
plethora of published literature supports the contention that dietary omega-3 
polyunsaturated fatty acids (PUFA), eicosapentaenoic (EPA, 20:5n-3) and 
docosahexaenoic acid (DHA, 22:6n-3) in particular, are important modulators of a host’s 
inflammatory/immune responses (7-9). 
 These studies demonstrate that EPA and DHA reduce pro-inflammatory 
responses, in part, by diminishing T cell proliferative capacity in response to both 
mitogenic and antigenic stimulation (10). Previous studies have  demonstrated that n-3 
PUFA modulate CD4+ T cell immune response via reduction in T-helper 1 (Th1) 
effector cell clonal expansion mediated, in part, by diminished interleukin-2 (IL-2) 
secretion and IL-2R • -chain mRNA transcription (11, 12).  However, the molecular 
mechanisms by which n-3 PUFA suppress CD4+ T cell function are not fully understood.  
Recently, it was demonstrated that n-3 PUFA are capable of suppressing the localization 
and activation of signaling proteins at the IS in mouse T cells (12, 13).   
 Mammals cannot produce n-3 PUFA from the major n-6 PUFA found in the diet 
due to lack of • 15-desaturase activity.  Hence, it is necessary to enrich the diet with EPA 
and/or DHA to assess their biological properties in vivo.  However, transgenic mice 
expressing the fat-1 gene encoding an n-3 fatty acid desaturase cloned from 
Caenorhabditis elegans can catalyze the conversion of n-6 PUFA to n-3 PUFA by 
introducing a double bond into fatty acyl chains (14).   Therefore, the fat-1 mouse model 
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facilitates the investigation of the biological properties of n-3 PUFA in T cells without 
having to incorporate these fatty acids into the diet.  
 In this study, the effect of n-3 PUFA on T cell-APC interactions in fat-1 mice 
was investigated. Specifically, the effect of n-3 PUFA on the recruitment of 
mitochondria to the IS during the initial activation phase of T cells in contact with APCs 
and the consequent changes in Ca2+ signaling in T lymphocytes were investigated. We 
demonstrate for the first time that n-3 PUFA modulate the early Ca2+ mediated events 
following the interaction of T cell with APCs.  These results are consistent with the 
ability of n-3 PUFA to inhibit downstream signaling and suppress T cell activation. 
 
1.1 Hypotheses   
 Using the fat-1 mouse model, the effect of n-3 PUFA on mitochondrial 
translocation and Ca2+ uptake at the T cell immunological synapse were investigated.  
Based upon earlier documentation of suppression of localization and activation of 
signaling proteins at the IS by dietary EPA and DHA, it was hypothesized that n-3 
PUFA enrichment of T cell membranes of fat-1 mice will (Figure 1);   
1) Suppress the localization of mitochondria at the IS of CD4+ T cells,  
2) Inhibit Ca2+ uptake by mitochondria at the IS, and 
3) Decrease the mitochondrial-to-cytosolic Ca2+ ratio. 
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Figure 1. n-3 PUFA inhibits mitochondrial translocation and suppresses Ca2+ -dependent T cell activation. 
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1.2  Experimental approach 
1.2.1  Specific aim 1 
Determine if n-3 PUFA inhibit mitochondrial translocation to the vicinity of the 
immunological synapse. 
To investigate the effect of endogenous n-3 PUFA on mitochondria translocation 
to the immunological synapse, Mitotracker green labeled CD4+ T cells from fat-1 and 
WT mice were be cocultured with anti-CD-3 hybridoma cells at 37°C in 5% CO2 for 0-
30 min.  Images of conjugate CD4+ T cells and hybridoma cells were captured, whereas 
non-contact CD4+ T cells serve as negative controls.  An assessment of mitochondrial 
translocation to the IS over time was assessed. The DNP –specific Ab expressing 
hybridoma were also used as a negative control.   
1.2.2 Specific aim 2 
Determine if n-3 PUFA reduce Ca 2+ uptake by mitochondria at the immunological 
synapse. 
Mitochondrial modulation of CRAC channel activity is involved in mediating the 
translocation of mitochondria toward the IS at the plasma membrane (5). Translocation 
to the IS allows mitochondria to take up a large amount of incoming Ca2+ directly 
beneath the mouth of the channels, thereby reducing channel inactivation (5). Therefore, 
the effect of n-3 PUFA on mitochondrial Ca2+ levels using Mitotracker Green and Rhod-
2 AM probes in splenic CD4+ T-cells from fat-1 and WT mice were investigated. 
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1.2.3 Specific aim 3 
Determine if n-3 PUFA modulates intracellular calcium signaling by altering the 
mitochondrial-to-cytosolic Ca2+ ratio.  
To further document the effects of n-3 PUFA on intracellular Ca2+ signaling in T 
cells, Fluo-4, a visible wavelength non-ratiometric cytosolic indicator that exhibits a 40-
fold increase in fluorescence intensity with Ca2+ binding (7), was loaded along with 
Rhod-2 AM (2.5µM) in order to evaluate the mitochondria-to-cytosolic Ca2+ ratio.  The 
relative fluorescence intensities of Rhod-2 to Fluo-4 was  measured in order to determine 
the mitochondrial-to-cytosolic ratio in living CD4+ T cells from fat-1 and WT mice. To 
further evaluate the role of mitochondrial Ca2+ uptake, cells were pre-incubated with 10 
µM RU-360, an inhibitor of mitochondrial uniporter, for 30 min prior to coculture with 
hybridoma cells. Cells were then co-loaded with fluorescent Ca2+ indicators and the ratio 
of cytosolic to mitochondrial Ca2+ was measured as described in materials and methods 
section.  To examine the influx of Ca2+ from the extracellular environment through the 
calcium dependent  membrane channel; in separate  experiments; cells were incubated 
with 10 µM BTP2, a pharmacological inhibitor of CRAC/ORAI1 channel activity, for 1 
h prior to the calcium labeling with Rhod-2 and Fluo-4, subsequently mitochondrial-to-
cytosolic Ca2+ ratio was determined.  
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CHAPTER II 
MATERIALS AND METHODS 
 
2.1 Materials 
 RPMI 1640 medium and sodium pyruvate were purchased from Cellgro 
(Manassas, VA). Fetal bovine serum (FBS) was purchased from Irvine Scientific (Santa 
Ana, CA). DMEM 1X medium, Leibovitz medium, Penicillin, Streptomycin and 
Glutamax were purchased from Gibco (Carlsbad, CA). Fluo-4 AM, Rhod-2 AM, and 
MitoTracker Green FM were purchased from Molecular Probes (Eugene, OR).  RU-360 
and BTP2 were purchased from Calbiochem (San Diego, CA). Two-well Lab-Tek 
chambered cover glass slides were purchased from Nunc (Naperville, IL).  Poly-L-lysine 
solution was purchased from Sigma-Aldrich (St. Louis, MO).  Stock solutions of 
mitotracker green, Fluo-4 AM, Rhod-2 AM and BTP2 were prepared in DMSO and 
diluted with medium to 100 nM, 1.0 µM, 1.5 µM, and 10 µm, respectively (final 
concentration of the vehicle DMSO was maintained at 0.1–0.3% in culture). Stock 
solutions of RU-360 was prepared in degassed water and diluted with medium to a final 
concentration of 10 uM.  
 
2.2 Cell culture 
 Hybridoma cells expressing hamster mAbs specific for either murine CD3 (clone 
145-2C11) or an irrelevant antigen, DNP (clone UC8-1B9, anti-DNP hybridoma) were 
obtained from American Type Culture Collection (Manassas,VA).  Cells were 
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maintained in DMEM-1X with 10% FBS, 4 mM L-glutamine, 1 mM sodium pyruvate, 
nonessential amino acids, and 105 U/L penicillin and 100 mg/L streptomycin at 37°C and 
5% CO2.  In addition to the presence of CD3 engagement, both types of hybridoma also 
display significant surface levels of the co-stimulatory ligands B7 and ICAM-1, which 
are capable of engaging their counterparts on the T cell (15).  This model has been 
extensively used to examine T cell/APC interaction (16). 
 
2.3 Animals and CD4+ T cell isolation 
   Fat-1 transgenic mice were generated and backcrossed onto a C57BL/6 
background as previously described (14, 17).  All procedures followed guidelines 
approved by Public Health Service and the Institutional Animal Care and Use 
Committee at Texas A&M University.  The colony of fat-1 mice used for this study was 
generated by breeding heterozygous mice.  Mice were genotyped using tail DNA.  To 
confirm the phenotype, total lipids were isolated from splenic T-cells and the fatty acid 
profile was characterized by gas chromatography as previously described (17, 18).  
Specific pathogen-free animals were maintained under barrier conditions and were fed a 
10% safflower oil diet (n-6 PUFA rich, Research Diets) ad libitum with a 12 h light/ 
dark cycle. The diet contained 40 (g/100 g diet) sucrose, 20 casein, 15 corn starch, 0.3 
DL-methionine, 3.5 AIN 76A salt mix, 1.0 AIN 76A mineral mix, 0.2 choline chloride, 5 
fiber (cellulose), 10 safflower oil. CD4+ T cells from fat-1 or wild type mice were 
isolated from spleens by a magnetic microbead positive selection method (13). 
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2.4 CD4+ T cell mitochondria labeling using Mitotracker Green FM 
(mitochondrial localization probe) 
 Purified (>92.0 % determined by flow cytometry) CD4+ T cells (2 x 106 cells/ml) 
were labeled with Mitotracker Green FM for 15 min at 37°C in RPMI 1640 (complete 
medium with 10% FBS). Mitotracker Green is a green-fluorescent mitochondrial stain 
that localizes in the mitochondria regardless of membrane potential (19) (Figure 2). This 
probe is essentially nonfluorescent in aqueous solution, only becoming fluorescent when 
it accumulates in the lipid environment of the mitochondria.  
 
2.5 CD4+ T cell mitochondria Ca2+ labeling using Rhod-2 AM (mitochondrial 
Ca2+ indicator) 
 Isolated CD4+ T cells (2 x 106 cells/ml) were labeled with red fluorescent dye, 
Rhod-2 AM for 30 min at 37°C.  Cells were subsequently washed to remove cytosolic 
Rhod-2 and resuspended in serum-free Leibovitz medium. Mitotracker Green FM was 
used to confirm that Rhod-2 fluorescence corresponded to mitochondrial Ca2+ 
accumulation (19) (Figure 2).  
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Figure 2. Experimental design to investigate the effect of n-3 PUFA on mitochondrial translocation and 
Mitochondrial Ca2+. 
 
2.6 CD4+ T cell mitochondrial-to-cytosolic calcium labeling using Rhod-2 AM 
and Fluo-4 (cytosolic Ca2+ indicator) 
 Isolated CD4+ T cells (2 x 106 cells/ml) were incubated with green fluorescent 
dye, Fluo-4, and red fluorescent dye, Rhod-2, for 1 h at 37°C.  Fluo-4 is a visible 
wavelength non-ratiometric cytosolic Ca2+ indicator that exhibits a 40-fold increase in 
fluorescence intensity with Ca2+ binding (20).  Following 1 h incubation with the probe, 
cells were washed with Leibovitz medium and imaged. The ratio of the cytosolic-to-
mitochondrial Ca2+ level was subsequently calculated.  In addition, experiments were 
performed in cultures incubated with RU-360, an inhibitor of mitochondrial uniporter, 
for 30 min prior to the calcium labeling with Rhod-2 and Fluo-4, following which the 
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mitochondrial-to-cytosolic Ca2+ ratio was determined. In separate experiments, cells 
were incubated with BTP2, a pharmacological inhibitor of CRAC/ORAI1 channel 
activity (21, 22), for 1 h prior to the calcium labeling with Rhod-2 and Fluo-4, after 
which the mitochondrial-to-cytosolic Ca2+ ratio was determined. The mitochondrial-to-
cytosolic Ca2+ ratio represents the relative fluorescence intensities of Rhod-2 and Fluo-4. 
 
2.7 CD4+ T-cell activation and fluorescence microscopy 
  For mitogenic CD4+ T cell activation, an anti-CD3 expressing hybridoma (clone 
145-2C11, ATCC) was used.  Mitotracker / Rhod 2 labeled CD4+ T cells were co-
incubated with hybridoma cells at a 5:1 ratio. Cell mixtures were seeded onto poly-L-
lysine pre-coated Lab-tek two-well chambered coverglass slides (2 x 106 CD4+ T-
cells/chamber).  Cell co-cultures were incubated for 15 min at 37°C in 5% CO2.  For 
quantification of Rhod-2 and Fluo-4 fluorescence, excitation wavelengths of 488 and 
550 nm were used and fluorescence emission was monitored at 530 and 590 nm, 
respectively.  Ten-15 areas with 20–25 cells per area and 4–8 wells per treatment were 
imaged with a 510 META NLO laser scanning microscope (Carl Zeiss Microimaging, 
Thornwood, NY) equipped with an argon laser and LSM software.  Images were 
collected using a 63X objective (1.3 numerical aperture).  To validate IS formation, T 
cells were incubated with irrelevant DNP-specific Ab expressing hybridoma cells (clone 
UC8-1B9, anti-DNP hybridoma) as a negative control (13, 16). 
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2.8 Image processing and quantification of mitochondrial-to-cytosolic Ca2+  
 All images were acquired by confocal microscopy and were converted to 8-
bit/channel TIFF format, and the percentage of cells with mitochondrial translocation to 
the IS was determined. To assess mitochondria-to-cytosolic calcium at the synapse and 
whole cell, polygons were drawn to designate the IS and the contact whole cell area. The 
normalized Rhod-2 intensity, an indicator of mitochondrial calcium, and normalized 
Fluo-4 intensity, an indicator of cytosolic calcium, was calculated by using mean 
fluorescence intensity (MFI) according to the formula: (Rhod-2 MFI / Fluo-4 MFI at the 
synapse and contact whole cell). Calcium measurements were determined in individual 
cells for each experiment, and comparisons were made with same day controls, 
including inhibitors. Quantitative analysis of MFI was performed using Adobe 
Photoshop CS3 for Windows.  
2.8.1  Statistical analysis 
 The effect of the independent variable (fat-1 vs wild type) was assessed using 
SPSS 15.0 for Windows.  Data are expressed as mean ±SE.  More than three 
independent experiments were performed for each experimental condition.  Differences 
between means were tested using t/F- type tests of contrast (two-tailed).  P values <0.05 
were considered to be statistically significant.  
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CHAPTER III 
RESULTS 
 
3.1  n-3 PUFA inhibit mitochondrial translocation to the vicinity of the 
immunological synapse 
 Both fat-1 transgenic and wild type control offspring were fed a 10% safflower 
diet enriched in n-6 PUFA throughout the duration of the study. To investigate the effect 
of endogenous n-3 PUFA on mitochondria translocation to the immunological synapse, 
Mitotracker green labeled CD4+ T cells were cocultured with anti-CD-3 hybridoma cells 
at 37°C in 5% CO2 for 0-30 min.  Images of conjugate CD4
+ T cells and hybridoma cells 
were captured, whereas non-contact CD4+ T cells served as negative controls.  The 
DNP–specific Ab expressing hybridoma was used as a negative control, and failed to 
exhibit direct mitochondrial translocation to the immediate vicinity of the IS formation 
(Figures 3A - C).  Typically, greater than 75% of wild type (control) CD4+ cells 
exhibited a directed movement of mitochondria to the IS by 15 min (Figures 3C & D).  
In contrast, CD4+ T cells from fat-1 mice had a significantly (p<0.05) reduced 
percentage of cells with mitochondria translocation to the IS (Figure 4). Typically, 
mitochondria in T cells are localized preferentially in one area of the cell (5). This 
apparent polarized mitochondrial localization may be caused by the rather large nucleus 
in T cells, and explains why a “localized” mitochondrial distribution was observed 
(Figure 3B).   
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In independent experiments in our laboratory, total lipid fatty acid compositional 
analyses of the fat-1 CD4+ T cell revealed an increase in n-3 PUFA, EPA (20:5 n-3), 
docosapentaenoic acid (22:5 n-3) and DHA (22:6 n-3), and decrease in n-6 PUFA, 
arachidonic acid (20:4n-6), adrenic acid (22:4n-6), and docosapentaenoic acid (22:5n-6) 
(13).  In addition, the ratio of n-6 to n-3 PUFA was significantly (p<0.05) suppressed in 
fat-1 compared with wild type cells. This indicates that an appropriate activity of n-3 
fatty acid desaturase was present and that T cells from fat-1 mice were enriched in n-3 
PUFA. These data demonstrate that n-3 PUFA suppress mitochondrial localization to the 
IS.
15 
 
 
 
 
Figure 3. Focal stimulation of T cell receptor activates mitochondrial translocation to the immunological synapse (IS). (A) Schematic of immunological 
synapse (positive control) formation (left) and non-contact (negative control) immunological synapse (right).  (B) Immunofluorescence images from 
MitoTracker Green/AM loaded CD4+ T-cells co-cultured with (left) anti CD3 (positive control) and (right) anti-DNP (negative control) hybridoma.  
Scale bar represents 5 µm.  (C) Summary image analysis of subplasma membrane localization of mitochondria in wild type CD4+ T cells after 15 min 
co-stimulation with anti-CD3 expressing Hybridoma 145-2C11 (positive control) and irrelevant expressing Ab Hybridoma UC8-1B9 (negative control), 
mean ± SEM of n=21-31 cells.  (D) Confocal fluorescence images from a single Mitotracker Green/AM- loaded CD4+ T cell forming an immunological 
synapse with an antigen-presenting cell (APC).  Image kinetics were measured from time 0 to 30 min following co-incubation of Mitotracker loaded 
(bright green) CD4+ T cells (from a wild type/control mouse) with APC (Hybridoma 145-2C11).  Images in each panel represent the same co-incubated 
cells (7-26 min).  Green patching represents mitochondria location in the T cell.  Scale bar represents 5 µm.   
15 
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Figure 4. n-3 PUFA suppress mitochondria translocation to the immunological synapse. Subplasma membrane localization of mitochondria to the 
immunological synapse was quantified in CD4+ T cells (n=140 cells from 5 fat-1 mice) after a 15 min co-stimulation with Hybridoma 145-2C11 
antigen-presenting cells.  Percentage of cells exhibiting mitochondrial translocation, fat-1 vs wild type (n=102 cells from 5 wild type mice) comparison.  
Asterisk indicates significant difference at p<0.05. 
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3.2 n-3 PUFA reduce Ca2+ uptake by mitochondria at the IS  
Mitochondrial modulation of CRAC channel activity is involved in mediating the 
translocation of mitochondria toward the IS at the plasma membrane. Translocation to 
the IS allows mitochondria to take up a large amount of extracellular Ca2+ directly 
beneath the mouth of the channels, thereby reducing channel inactivation (5). Therefore, 
we examined the effect of n-3 PUFA on mitochondrial Ca2+ levels using Mitotracker 
Green and Rhod-2 AM probes.  In this double-labeling experiment, Rhod-2 at the 
synapse is an indicator of mitochondrial Ca2+ because of the much higher colocalization 
of both dyes.  Figure 5A shows representative images documenting differential 
intracellular localization of Ca2+ in mitochondria (yellow pixels).  In addition, 
mitochondrial Ca2+ was measured within the region of interest near the IS (Figure 5B).  
In cells exhibiting mitochondrial translocation to the IS, no significant differences in 
Ca2+ concentration between the wild type and fat-1 T cells was observed (Figure 5C).  
In contrast, there was a significant reduction in Ca2+ levels (p<0.05) at the IS in fat-1 T 
cells when both translocated and non-translocated mitochondria data were combined 
(Figure 5D).  These results indicate that T cell Ca2+ signaling at the IS is suppressed in 
CD4+ T cells enriched with n-3 PUFA. The higher intramitochondrial Ca2+ at the IS is 
probably caused by the intimate contact between mitochondria and the IS, which 
exposes mitochondria to higher microenvironments of Ca2+.   
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Figure 5.  Measurement of Ca2+ uptake at the immunological synapse.   (A) Shows the region of interest where calcium signal is observed.  (A1) T cell 
with mitochondrial translocation to the IS. (A2) cell exhibiting a failure to translocate mitochondria to the IS, and (A3) T cell with no contact, therefore 
no IS is formed.  (B) Representative confocal microscopy images of Rhod-2 and Mitotracker labeled cells (B1) RGB, (B2) green, (B3) red channels, 
respectively.  Regions of interest (ROI) at the T cell immune synapse were selected by drawing an oval or polygon as shown in dotted lines.  Mean 
intensities from red and green channels were recorded to calculate Ca2+ values as described in the Methods.  Scale bar, 5 µm.  (C) Effect of n-3 PUFA 
on Mitochondrial Ca2+ at the immunological synapse only in cells with mitochondrial translocation to the IS.  (D) Comparison of mitochondrial Ca2+ 
measurements in CD4+ T cells in wild type (n=26 cells 3 mice) and fat-1 (n=18 cells from 3 mice).  Asterisk indicates significant difference at p<0.05.  
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3.3 n-3 PUFA modulate intracellular calcium signaling by altering the 
mitochondrial-to-cytosolic Ca2+ ratio  
Since mitochondria are key organelles involved in the regulation of intracellular 
Ca2+ homeostasis, the ratio of mitochondrial-to-cytosolic Ca2+ in individual cells was 
measured. Fluo-4, a visible wavelength non-ratiometric cytosolic indicator, was loaded 
along with Rhod-2 AM in order to evaluate the mitochondrial-to-cytosolic Ca2+ ratio.  
The relative fluorescence intensities of Rhod-2 to Fluo-4 were measured to determine 
the mitochondrial-to-cytosolic ratio in living CD4+ T cells from fat-1 and wild type 
mice.  Since IS formation, mitochondrial translocation, and Ca2+ influx peaks by 
approximately 30 min (23), mitochondrial-to-cytosolic ratio data were collected over a 
15-30 min time interval.  Figure 6A shows representative images of Fluo-4 and Rhod-2 
labeled cells.  In wild type cells, an increasing trend of mitochondrial-to-cytosolic ratio 
is observed over time at both the IS and the whole cell (Figure 6B & C).  In contrast, 
mitochondrial-to-cytosolic ratio shows no change after the IS formation in the fat-1 cells, 
both at the IS and the whole cell (Figure 6D & E).  Comparison between the 
mitochondrial-to-cytosolic ratio of wild type and fat-1 cells at 15 min was not significant 
(p>0.05) at both the IS and the whole cell level.  In contrast, at 30 min, significant 
differences (p<0.05) were observed in the mitochondrial-to-cytosolic ratio of wild type 
versus fat-1 cells at the IS and the whole cell (Figure 6E).  These data are consistent 
with an inhibitory effect of n-3 PUFA on the uptake of calcium by mitochondria after IS 
formation.
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Figure 6.  Effect of n-3 PUFA on intracellular Ca2+.  CD4+ T cells were coincubated with Fluo-4 AM (3 µM) and Rhod-2 AM (2.5 µM) for 30 min and 
the mitochondrial-to-cytosolic Ca2+ ratio was determined.  (A) Representative confocal microscopy images of Fluo-4 and Rhod-2 labeled cells (A1) 
white, (A2) RGB, (A3) green, (A4) red channels, respectively.  (B) Amplitude of intracellular Ca2+ response at the immunological synapse (IS) in wild 
type CD4+ T cells after co-culture with Hybridoma 145-2C11 antigen presenting cells.  Data are from a representative experiment, 15-30 min after co-
culture, n=5 independent experiments, 10-20 cells.  (C) Amplitude of total intracellular Ca2+ response in wild type CD4+ T cells.  (D) Amplitude of 
intracellular Ca2+ response at the immunological synapse in fat-1 CD4+ T cells.  (E) Amplitude of total intracellular Ca2+ response in fat-1 CD4+ T cells.  
(F) Comparison of relative mitochondrial-to-cytosolic Ca2+ ratio at the immunological synapse versus total cell in CD4+ T cells from wild type (n=116 
cells from 4 mice) and fat-1 mice (n=131 cells from 5 mice).  Asterisk indicates significant difference at p<0.05.  (Left) Measurement at 15 min 
following the immunological synapse formation.  (Right) Measurement at 30 min, the peak of response.  
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3.4 Effect of a mitochondrial uniporter inhibitor on intracellular Ca2+ levels  
To investigate the role of the mitochondrial uniporter in Ca2+ uptake, cells were 
treated with RU-360, a mitochondrial Ca2+ uniporter inhibitor (24). Following IS 
formation, the mitochondrial-to-cytosolic ratio in both the wild type and fat-1 cells co-
incubated with RU360 showed no change up to 30 min (Figures 7A - D).  Significant 
differences (p<0.05) in the mitochondrial-to-cytosolic Ca2+ ratio were observed in wild 
type cells and fat-1 cells minus RU-360 both at IS and the whole cell at 30 min (Figure 
7E).  These data are consistent with the role of mitochondrial uniporter activity in 
regulating intracellular Ca2+ following IS formation.   
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Figure 7.  Effect of mitochondrial uniporter inhibitor (RU-360) on intracellular Ca2+.  CD4+ T cells from 
wild type and fat-1 mice were preincubated with RU-360 (10 µM) for 30 min, followed by washing and 
coincubation with Fluo-4 AM (3 µM) and Rhod-2 AM (2.5 uM) for 30 min and the mitochondrial-to-
cytosolic Ca2+ ratio was determined.  (A) Amplitude of intracellular Ca2+ response at the immunological 
synapse (IS) with RU-360 in wild type CD4+ T cells after 15 min co-culture with Hybridoma 145-2C11 
antigen presenting cells.  Data are from a representative experiment, 15-30 min after co-culture, n=2-3 
independent experiments, 15-18 cells.  (B) Amplitude of total intracellular Ca2+ response with RU-360 in 
wild type CD4+ T cells after 15 min co-culture with Hybridoma 145-2C11 antigen presenting cells.  (C) 
Amplitude of intracellular Ca2+ response at the immunological synapse with RU-360 in fat-1 CD4+ T cells.   
(D) Amplitude of total intracellular Ca2+ response with RU-360 in fat-1 CD4+ T cells.  (E) Comparison of  
relative mitochondrial-to-cytosolic Ca2+ ratio at the immunological synapse vs. total cell in CD4+ T cells 
from wild type (n=66 cells from 2 mice) and fat-1 (n=92 cells from 3 mice).  Asterisk indicates significant 
difference at p<0.05.  (Left) Measurement with and without RU-360 at 15 min following immunological 
synapse formation.  (Right) Measurement with and without RU-360 at 30 min, the peak of response.  
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3.5 Effect of CRAC/ORAI1 channel blocker on intracellular Ca2+ levels  
Since sustained Ca2+ influx across the plasma membrane though CRAC channels 
is required for T cell activation (25), the effects of BTP2, a CRAC/ORAI1 channel 
blocker, was evaluated in wild type CD4+ T cells.  As shown in Figures 8A – C, the 
mitochondrial-to-cytosolic ratio at the IS and in the whole cell did not show any increase 
over time.  These data suggest that inactivation of CRAC/ORAI1 channels inhibits the 
influx of extracellular Ca2+ preventing the increase in mitochondrial-to-cytosolic Ca2+ 
ratio necessary for downstream effector pathway activation. 
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Figure 8.  Effect of CRAC/ORAI1 channel blocker (BTP2) on intracellular Ca2+.  CD4+ T cells of wild 
type mice were preincubated with BTP2 (10 µM) for 1 h following which cells were washed and 
coincubated with Fluo-4 AM (3 µM) and Rhod-2 AM (2.5 uM) for 30 min and the mitochondrial-to-
cytosolic Ca2+ ratio was determined.  (A) Amplitude of intracellular Ca2+ response at the immunological 
synapse (IS) with BTP2 in wild type CD4+ T cells after a 15 min co-culture with Hybridoma 145-2C11 
antigen presenting cells (n=15-19 cells from 15 to 30 min following IS formation).  (B) Amplitude of total 
intracellular Ca2+ response with BTP2 in wild type CD4+ T cells.  (C) Comparison of relative 
mitochondrial-to-cytosolic Ca2+ ratio at the immunological synapse versus total cell in wild type CD4+ T 
cells (n=35 cells). Asterisk indicates significant difference at p<0.05.  
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CHAPTER IV 
DISCUSSION AND CONCLUSION 
 
 Autoimmune and/or chronic inflammatory diseases primarily involve an 
overactive immune response directed towards a particular tissue (26). Improper T cell 
regulation results in an imbalance between T cell activation and suppression resulting in 
chronic inflammation. For example, hyperactivation of CD4+ T cells is associated with 
enhanced susceptibility to autoimmune disorders and chronic inflammation induced 
diseases (27). A plethora of studies demonstrate that T cell activation is suppressed by n-
3 PUFA/DHA, in part, by altering the physical properties of biological membranes (10-
13, 18, 28, 29). To further investigate the immunomodulatory effects of n-3 PUFA, in 
vivo mitochondrial translocation and calcium homeostasis in T lymphocytes following 
immunological synapse formation were investigated. There is evidence that 
mitochondria translocate toward the immunological synapse in CD4+ and Jurkat T cell 
lines (5, 25, 30).  Recently, the re-organization of mitochondria at the NK cell synapse 
has been documented (31). 
 To our knowledge this is the first study to investigate the effects of n-3 PUFA on 
critical early Ca2+-mediated events of T cell activation. For this purpose, fat-1 transgenic 
mouse model was used to test the hypothesis that n-3 PUFA inhibit mitochondrial 
translocation and, therefore, suppress sustained Ca2+ signaling necessary for T cell 
activation. The fat-1 transgenic mouse model was utilized because it is capable of 
converting n-6 PUFA to n-3 PUFA endogenously by introducing a cis-double bond into 
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fatty acyl chains (14, 17). This model allows us to investigate the biological properties of 
n-3 PUFA without having to incorporate the fatty acid in the diet.  
Recent evidence indicates that upon initial contact between APCs and T cells, 
mitochondria are recruited to the immediate vicinity of the immunological synapse (5).  
This critical event is followed by a reduction in the local accumulation of Ca2+ so as to 
maintain the robust influx of Ca2+ across the plasma membrane through CRAC channels, 
resulting in the activation of key downstream transcription factors such as NFAT 
(5).Previously it has been demonstrated that incorporation of n-3 PUFA into cytofacial 
leaflet phospholipids alters the lateral composition of lipid rafts in the plasma membrane, 
thereby altering the IS microenvironment to impact thresholds for the activation of TCR-
mediated cell signaling.  Thus, n-3 PUFA-enriched CD4+ T cells exhibit a suppressed 
localization of important signaling proteins, such as F-actin, PLC•-1, and PKC• , into the 
IS as assessed by immunofluorescence labeling (13).  Therefore, it was hypothesized 
that n-3 PUFA would suppress CD4+ T cell mitochondrial translocation during the early 
stages of IS formation and down-modulate Ca2+ dependent signaling.  Our data 
demonstrate that n-3 PUFA suppress the activation of T cells, in part, by inhibiting 
mitochondrial translocation to the immunological synapse.  Specifically, experiments 
showed that CD4+ T cells from fat-1 mice had a significantly reduced percentage of cells 
that exhibited mitochondrial translocation to the IS as compared to cells isolated from 
wild type mice.   
 The sustained activity of Ca2+ channels in the plasma membrane requires 
translocation of mitochondria to the plasma membrane (5).  This is attributed to the fact 
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that the decreased distance between mitochondria and the plasma membrane enables 
mitochondria to take up large amounts of extracellular Ca2+, thereby preventing Ca2+-
dependent inactivation of CRAC channels, and sustaining Ca2+-dependent signaling.  
Since mitochondrial translocation was inhibited in T cells isolated from fat-1 transgenic 
mice,  further study was done to examine the effect of n-3 PUFA enrichment on 
intracellular Ca2+ homeostasis in T cells using a double excitation technique, i.e., 
excitation at two wavelengths (488 nm and 550 nm) to determine increases in [Ca2+]i.  
This technique corrects for errors that are caused by the shift in the spectrum from one 
wavelength to another during increases in intracellular Ca2+ (20).  As anticipated, the 
inhibition of mitochondrial translocation in fat-1 T cells was associated with a reduction 
in mitochondrial Ca2+ uptake near the IS. It was also noted that the mitochondrial-to-
cytosolic Ca2+ ratio remained unchanged in n-3 PUFA enriched (fat-1) T cells following 
IS formation.  In contrast, wild type cells showed an increasing trend with respect to the 
mitochondrial-to-cytosolic ratio Ca2+ over time at both the IS and the whole cell.  These 
data are noteworthy, because Ca2+ mediated regulation of CRAC channels in T cells 
enable sustained elevation of intracellular Ca2+, an obligate requirement to drive nuclear 
translocation of NFAT (32).  Maintenance of nuclear localization of NFAT is a 
prerequisite for the expression of interleukin-2 and other T cell activation responses after 
exposure to antigen (33, 34).  In the absence of mitochondrial translocation and, hence, 
mitochondrial Ca2+ uptake, the local accumulation of Ca2+ near the IS inactivates 
CRAC/ORAI1 channel quickly and reduces Ca2+ entry into the cell (5).  Our results 
reaffirm the importance of mitochondrial translocation, and demonstrate for the first 
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time that n-3 PUFA are capable of decreasing mitochondrial Ca2+ uptake, thereby 
impairing a universal second messenger pathway important for T cell activation. 
To address the integration and crosstalk between Ca2+ and other signaling 
pathways in our T cell model system, proof-of-principle experiments were also 
conducted using mitochondrial uniporter (RU-360) and CRAC/ORAI1 channel (BTP2) 
inhibitors.  As anticipated, following immunological synapse formation, mitochondrial-
to-cytosolic Ca2+ ratios in both wild type and fat-1 cells co-incubated with RU-360 were 
similar.  In contrast, in the absence of RU360, the ratio was elevated only in wild type 
cells.  In complementary experiments, inactivation of the CRAC/ORAI1 channel 
prevented the synapse-induced increase in the mitochondrial-to-cytosolic Ca2+ ratio.  
These data corroborate the functional link between mitochondrial regulation of 
CRAC/ORAI1 and T cell activation.  Our results stress the importance of mitochondria 
in regulating Ca2+ channel activity and signal transmission from the plasma membrane to 
the nucleus during the earliest stages of T cell activation.  Therefore, the 
immunosuppressive effects of n-3 PUFA on T cell function can be attributed, in part, to 
modulation of mitochondria-dependent intracellular Ca2+ signaling. 
Although previous studies have examined the effects of diet with regard to 
immunosuppression (27, 35, 36), it is apparent that n-3 PUFA profoundly reduce the 
translocation of mitochondria to the immediate vicinity of the IS (Figure 9).  This, in 
turn, reduces Ca2+ uptake by mitochondria, diminishing the “local” cytosolic Ca2+ 
concentration, which limits Ca2+ influx through CRAC/ORAI1 channels.  Ultimately, 
lower intracellular Ca2+ inactivates the phosphatase calcineurin, and reduces the 
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subsequent nuclear import and assembly of NFAT transcription complexes essential for 
T cell activation (3, 4, 34).  With regard to mechanisms which modulate mitochondrial 
motility, there is evidence that n-3 PUFA can displace F-actin from the IS, where T cells 
and APC form a conjunction (13, 28).  This is noteworthy, because mitochondria 
predominantly interact with the actin cytoskeleton and use actin tracks to coordinate the 
relative distance between the IS and mitochondria (5, 37, 38).  Further work is needed in 
order to dissect the effects of membrane lipid composition on microtubule based 
mitochondrial mobility and the overall actin morphology that provides the dynamic 
cellular framework that is required to facilitate several complex cytoskeleton-dependent 
processes and ultimately control T cell activation. 
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Figure 9. Effect of n-3 PUFA on Ca2+-dependent T cell activation.  (A) Schematic model showing the role of mitochondria during T cell activation by 
antigen.  Upon formation of the IS between an APC and T helper (Th) cell, mitochondria translocate to the immediate vicinity of the IS. Once recruited 
to the IS, mitochondria reduce local Ca2+ accumulation, thereby sustaining Ca2+ influx through CRAC/ORAI1 channels.  Increase in the intracellular 
calcium [Ca2+]i concentration leads to calcium and calmodulin binding to the calcium-calmodulin-dependent phosphatase, calcineurin. Calcineurin then 
dephosphorylates transcription factors, e.g., NFAT, which translocate to the nucleus and remain in a transcriptionally active state.  (B) The incorporation 
of n-3 PUFA into the fat-1 CD4+ T cell plasma membrane increases the formation of lipid rafts at the IS and also alters the composition of mitochondrial 
membrane.  This results in the inhibition of mitochondrial translocation to the IS, thereby reducing Ca2+ uptake by mitochondria, limiting the cytosolic 
Ca2+ concentration, and blocking phosphatase activition of calcineurin. Collectively, these events reduce the dephosphorylation and nuclear 
translocation of NFAT and suppress the transcription of genes necessary for T cell activation. 
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In conclusion, these data demonstrate that n-3 PUFA suppress mitochondrial 
translocation to the immunological synapse and perturb Ca2+ signaling, which is critical 
to T cell activation.  These results provide a critical new paradigm in understanding the 
molecular mechanisms through which n-3 PUFA modulate T-cell activation. The series 
of events that control Ca2+ signaling in T cells is complex and more research will be 
needed to understand and to elucidate the precise molecular mechanism by which dietary 
n-3 PUFA modulate [Ca2+]i in T cells,  and control several key activation events that 
lead to the production of pro-inflammatory cytokines(TNF• , IL-1• , and IL-6)  and 
eicosanoids. Additional study need to be  conducted to reveal that n-3 PUFA  decreases 
NK cell activity, cytotoxic T lymphocyte activity, expression of the high affinity IL-2 
receptor alpha gene in activated lymphocytes, lymphocyte proliferation, and the 
production of IL-2. Furthermore the work was restricted to a transgenic animal model 
and there is an obvious need to examine these effects and mechanisms in the context of 
diet, where dose of active fatty acids available is of critical importance. 
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APPENDIX  
EXPERIMENTAL PROTOCOLS  
 
 
A-1. Fat-1 phenotyping 
*Always keep the samples in ice. 
I. D-1: Prepare leak proof tubes 
1. Put 1ml acetone in 12ml glass tubes with black caps (Teflon lined). 
2. Evaporate for 1hrs in 80 deg.C. oven. 
3. Check if acetone has evaporated. 
II. D-0: Extract total lipid 
1. Preset centrifuger at 4 deg.C. 
2. Clean 12ml tubes 
- Do in hood 
- Pour out acetone (into brown bottle) 
- Put upside down on the rack (don’t mix the caps) 
- Clean the tubes with 1ml methanol (GC grade). Use glass pipette 
3. Put 1ml cold 0.1M KCL with plastic pipette into 2ml epi-tubes. 
4. Cut the mouse tail to small pieces, into the tube from #3. 
5. Homogenize the sample with Polytron blade (Ultra-Turrax T8, IKA 
Labortechnik) at speed 5 for 15 sec. (Put the sample tube on ice during the 
homogenization). The tail mixture will turn brownish color. 
6. Add 5ml of Folch (CHCl3/MeOH, 2:1, v/v) into 12ml glass tube, then transfer 
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the sample to the tube. 
7. Vortex the sample for 1min. 
8. Centrifuge the sample at 3000rpm for 5min at 4deg.C. (Put the glass tube 
inside plastic tube wrapper to avoid breaking during the centrifugation). After 
centrifugation, set centrifuger temp. at 20 deg.C. 
9. Transfer lower phase to a leak-proof 12ml glass vial with Pasteur pipette. Put 
the bulb to make bubbling during passing the upper phase to avoid 
contamination. After getting out the pipette, throw away 1-2 drops. 
10. Wipe the needles of N2 dryer with MeOH in the hood. 
11. Dry sample under N2 
12. Mix 6% HCl-MeOH under the hood near walk in freezer. (HCl is under the 
hood, and GC-grade MeOH is near the balance). Use mass cylinder to 
measure. 
13. Add 3ml 6% HCl-MeOH to the tube. 
14. Flush sample with N2, close cap tight. 
15. Vortex and incubate at 76 dec.C. Oven for ~15 hrs. 
16. Prepare 4ml tubes with labels. (Recap with green Teflon caps). 
III. D+1: Extract FAME 
1. At this time, turn on GC 
2. Set centrifuger at 4 deg.C. 
3. Extract FAME by adding 1ml, cold 0.1M KCl and 2ml Hexane to the 
methylated sample. Vortex for 1min, centrifuge at 3000rpm for 5min at 
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4deg.C. 
4. Transfer upper phase to 4ml glass vial.  
5. Dry FAME under N2. 
6. Redissolve the sample in 25ul methylene chloride (CH2Cl2) 
- Pour CH2Cl2 into glass tube. 
- Use Wire Trol 25ul. 
7. Vortex the tubes in order to dissolve all the FAME on the wall. 
8. Ready for running on GC. 
IV. GC analysis 
1. Turn on GC, stabilize for 15min. 
2. Turn on computer, open 32 Karat 7.0 
3. Select GC, the OK. 
4. Click on single run icon (Blue single arrow), the screen shows “waiting for 
trigger” 
5. Then, inject std (68A std, Nuchek) 
- Find the tube with yellow tag in -20deg.C. freezer 
- Vortex 
- Rinse the inject needle with CH2Cl2 
- Load 0.5ul std in the needle: avoid any bubble. 
- Push the needle into injector inlet, the push the plunger. 
- Pull back the needle, then press “start” button on GC machine. 
- After injection, flush the tube with N2. 
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- Put back in -20deg.C. freezer. 
6. Vortex the sample and inject in the same way. 
7. For the report, 
- Click “3.2 Karat”, then “offline GC”. 
- Data  Open (D\GC\GCdata\wooki). 
- Method  integration events  minimum area  adjust  green 
(analyze). 
- Ctrl+z: escape highlight. 
- Method  custom report. 
- Double click on graph to change the Y axis range. 
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A-2. Representative GC profiles of Fat-1 phenotyping 
(A) WT 
 
(B) Fat-1 
 
 
 
20:4n-6 18:2n-6 
22:5n-6 
22:4n-6 
18:3n-3 
22:6n-3 
22:5n-3 
20:5n-3 
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ID Sex 
n-6     n-3     
n-6:n-3  
ratio 
Phenotype 18:2 20:4 22:4 22:5 Total 
n-6 
18:3 20:5 22:5 22:6 Total 
n-3 
974 F 19.7 1.2 0.4 0.3 21.6 2.1 1.7 1.2 1.3 6.3 3.4 Fat-1 
975 F 19.0 1.2 0.6 0.4 21.2 1.7 1.6 1.5 1.1 5.9 3.6 Fat-1 
979 F 19.2 1.7 0.7 0.6 22.2 1.5 1.5 1.4 1.3 5.7 3.9 Fat-1 
980 F 11.8 1.2 0 0 13.0 2.7 1.8 1.6 1.6 7.7 1.7 Fat-1 
962 M 15.8 6.6 1.5 1.3 25.2 0.0 0.0 0.0 0.0 0.0  WT 
968 M 13.7 6.1 1.6 1.2 22.6 0.0 0.0 0.0 0.0 0.0  WT 
1132 F 17.3 1.3 1.0 0.6 20.2 1.7 1.8 1.3 1.0 5.8 3.5 Fat-1 
1133 F 16.2 1.2 0.6 0.0 18.0 2.5 1.3 1.2 1.7 6.7 2.7 Fat-1 
1179 F 19.9 1.1 0.5 0.4 21.9 1.6 1.5 1.1 1.1 5.3 4.1 Fat-1 
1180 F 13.8 2.6 0 0 16.4 2.2 1.8 1.8 1.4 7.2 2.3 Fat-1 
742 M 19.6 1.2 0.6 0.4 21.8 1.3 1.4 1.1 1.0 4.8 4.5 Fat-1 
991 M 15.8 1.5 0.4 0.0 17.7 1.8 1.2 1.1 1.3 5.4 3.3 Fat-1 
998 M 16.3 1.3 0.5 0.0 18.1 2.1 1.1 1.0 1.2 5.4 3.4 Fat-1 
999 M 9.7 0.6 0.3 0.2 10.8 1.1 0.9 0.9 0.6 3.5 3.1 Fat-1 
961 M 18.9 1.5 0.5 0.4 21.3 1.4 1.4 1.5 1.3 5.6 3.8 Fat-1 
1243 M 17.8 1.7 0.5 0.4 20.4 1.7 3.5 1.6 1.2 8.0 2.6 Fat-1 
824 M 12.6 1.3 0.6 0 14.5 2.7 2.3 1.6 1.4 8.0 1.8 Fat-1 
973 M 11.3 0 0.7 0.2 12.2 3.3 2.6 1.8 1.5 9.2 1.3 Fat-1 
967 F 19.1 5.4 1.5 1.2 27.2 0.2 0.0 0.0 0.0 0.2 136.0 WT 
971 F 18.7 0.6 1.5 1.3 22.1 0.5 0.0 0.0 0.3 0.8 27.6 WT 
963 F 22.1 6.3 1.3 1.0 30.7 0.3 0.0 0.0 0.3 0.6 51.2 WT 
1175 F 20.2 5.6 1.4 1.3 28.5 0.2 0.0 0.0 0.0 0.2 142.5 WT 
1267 F 18.3 6.8 1.6 1.7 28.4 0 0 0 0 0.0  WT 
982 M 16.2 5.9 1.5 1.2 24.8 0.3 0.0 0.0 0.3 0.6 41.3 WT 
983 M 18.7 5.7 1.5 1.3 27.2 0.0 0.0 0.0 0.0 0.0  WT 
1268 F 25.4 1.4 0.7 0.5 28.0 0.8 1.0 0.8 0.6 3.2 8.8 Fat-1 
1269 F 16.2 1.1 0.5 0.0 17.8 1.9 1.4 1.2 1.6 6.1 2.9 Fat-1 
1270 F 20.1 0.7 0.5 0.0 21.3 2.1 0.9 0.8 1.1 4.9 4.3 Fat-1 
1244 M 8.5 0.6 0.9 0.0 10.0 3.2 2.0 1.5 2.0 8.7 1.1 Fat-1 
1266 M 12.8 1.8 0.7 0.4 15.7 1.8 1.4 1.2 1.3 5.7 2.8 Fat-1 
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A-3. Fat-1 genotyping  
I. Isolation of total DNA from mouse tail 
1. Material 
a. Mouse tail (~1cm), frozen in liquid nitrogen 
b. DNeasy Tissue Kit (Qiagen, cat# 69504) 
2. Preparation of reagent 
a. For the first time use, add appropriate amounts of 100% EtOH to Buffers 
AW1 and AW2 as indicated on the bottles. 
b. Prewarm 55 oC. shaking water bath (set as 75 rpm) 
3. Procedure (It is better to do this in the late afternoon) 
a. Perform all steps in RT, votex for 5-10 sec. unless specified 
b. Allow the frozen tail warm to RT. Put the tail on a new glass slide. 
c. Cut the tail to smaller pieces using brand new or DNA away-zapped razor 
blade. 
d. Transfer the tail pieces to a new 2mL sterile epi-tube. 
e. Add 180uL Buffer ATL into the tube. 
f. Add 20uL proteinase K into the tube and vortex (make sure all pieces are 
down) 
g. Incubate the tube (on a floating platform) in 55 oC. shaking water bath (75 
rpm) overnight (~16-18 hr). 
 
------------------------ Overnight---------------------------- 
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h. Mix 200uL Buffer AL and 200uL 100% EtOH to make Buffer ALE for each 
sample, using DNase free pipette-tips. (Make fresh) 
i. Remove the tube out of the water bath. Vortex for 15 sec. 
j. Add 400uL Buffer ALE to the sample, and mix vigorously by vortexing 
(make sure it mix thoroughly) 
k. Pipette the mixture to DNeasy Mini spin column placed in a 2mL collection 
tube (kit provided). 
l. Centrifuge at >6000 x g (8000 rpm) for 1 min. (Eppendorf centrifuge 5414D) 
m. Discard flow-through and collection tube. 
n. Place the DNeasy Mini spin column in a new 2mL collection tube (provided). 
o. Add 500uL Buffer AW1, and centrifuge for 1 min at >6000 x g (8000 rpm). 
p. Discard flow-through and collection tube. 
q. Place the DNeasy Mini spin column in a new 2mL collection tube (provided). 
r. Add 500uL Buffer AW2, and centrifuge for 3 min at 20,000 x g (14,000rpm) 
to dry the DNeasy membrane. (Centrifuge 5417R) It is important to 
completely dry the membrane, since EtOH will interfere with subsequent 
reactions. 
s. Discard flow-through and collection tube. 
t. Place the DNeasy Mini spin column in a new sterile 2mL collection tube with 
lid (not provided). Pipette 200uL of Buffer AE directly onto the DNeasy 
membrane. 
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u. Incubate in RT for 1 min, then centrifuge for 1 min at >6000 x g (8000 rpm) 
to elute the DNA 
v. Pipette 200uL of Buffer AE directly onto the DNeasy membrane, in the same 
2mL tube. 
w. Incubate in RT for 1 min, then centrifuge for 1 min at >6000 x g (8000 rpm) 
to elute the DNA in the same tube. 
 
II. DNA quantification 
1. Handle Quartz plate with lens cleaner, ALWAYS!!  Avoid “any” scratch !! 
2. Turn on Spectra Max and the Mac computer connected. (Prewarm 10-15 min) 
3. Find the “Spectra Max” icon on the Desktop, and double click it. 
4. Click “Set up”  Wavelength Lm1: 260 / Lm2: 280  Calibrate: On 
5. Place Quartz plate on the machine 
6. Find “Control” toolbar on menu  close tray 
7. Control  Run  Pre-read  OK 
8. The machine reads the plate, then the Quartz plate comes out. 
9. Save, and bring the plate to the bench table. 
10. Make 1X TE with 0.1% Tween 20  
11. Put 95uL TE buffer into designated wells (duplicate is better) 
12. Make it sure the first two wells are “Blank” 
13. Use DNA quantification control (~115 µg/mL, in Laurie’s freezer) 
14. Put 5uL of DNA samples into appropriate wells. 
48 
 
15. Bring the plate to the Spectra Max, and load the plate. 
16. Click Control  Close Tray  Read  Experiment  OK 
17. The machine reads the plate 
18. After the reading, click “Template” 
19. Drag wells which are used  Unknown 
20. Group number: 2 
21. Drag first two wells  Blank 
22. Then, look into result part 
23. Delete any unnecessary columns 
24. Calculate “MeanValues” for duplicates 
25. Calculate “DNA quantity (µg/mL) by formulation: MeanValues*20(dilution 
factor)*214(Correction) 
Correction table 
Volumn in Quartz plate DNA RNA 
200uL 93.6 83.0 
150uL 131.0 115.8 
100uL 214.0 191.3 
50uL 597.0 523.8 
 
26. Dilute DNA to make 10uL of 15 µg/mL DNA with ddH2O. For PCR use only, 
discard diluent after use. 
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III. RT-PCR (SYBR Green real time PCR, 7900HT) 
1. Per Reaction: 
2X SYBR Master Mix 6.25 uL 
Forward primer (300nM) 1uL 
Reverse primer (300nM) 1uL 
DNA (~15 µg/mL) 0.5uL 
ddH2O 3.75uL 
2. Make a cocktail with Maser Mix, both primers, and ddH2O. 
Master Mix 6.25uL x = uL 
F primer 1uL x = uL 
R primer 1uL x = uL 
ddH2O 3.75uL x = uL 
  Total cocktail volume uL 
 
a. Add 12uL of cocktail to plate and 0.5uL diluted DNA (Do in the hood for 
PCR, plate part# 4346906) 
b. Cover the plate with plastic cover. 
c. Squeeze with a rubber to ensure all wells are completely sealed. (If any well 
is not sealed, the material evaporates during PCR cycle). 
d. Centrifuge the plate several seconds. (When the centrifuge reaches up to 
1000 rpm, turn off). 
e. Run RT-PCR  
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3. RT-PCR running 
a. Turn on machine and computer 
b. Click SDS 2.2.2 on desktop 
c. File  new 
 Assay: Absolute quantification 
 Container: 96 well 
 Template: Blank  OK 
d. Designate sample-containing wells by click and dragging on plate map 
e. (Use CTRL key if you need to add/drop wells) 
f. Setup  add detector  SYBR  copy to plate documents  done 
g. Mark “X” on detector SYBR 
h. (Make sure that all sample-containing wells are designated and marked as 
SYBR) 
i. Instrument  Mode  Standard  Sample volume(µL)  13.0 
j.  Connect  open  load plate  close  start 
4. After RT-PCR is done 
a. Designate wells  analysis  analyze 
b. (10) Open  take out sample  done 
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A-4. Representative RT-PCR plots of Fat-1 genotyping 
 
Primers used: 
 
Fat-1 forward- tgt tca tgc ctt ctt ctt ttt cc 
 Fat-1 reverse- gcg acc ata cct caa act tgg a 
 
Run PCR with following conditions: 
 
1. 50 deg C   : 2 min  
2. 95 deg C   : 10 min                          40 cycles. 
3. 95 deg C   : 15 sec   
4. 60 deg C   : 1 min 
Fat-1 
WT 
52 
 
A-5. CD4+ T cell Positive Isolation by Miltenyi® Beads and Column 
 
Materials: 
--- 70 µm Cell Strainer (BD#352350, Fisher# 08-771-2) 
--- 30 µm MACS Pre-separation Filter (Miltenyi Biotec, cat# 130-041-407) 
--- CD4 (L3T4) Microbeads, mouse (Miltenyi Biotec, cat# 130-049-201) 
--- MACS Separation Columns, MS columns (Miltenyi Biotec, cat# 130-042-201) 
--- Octo MACS Separation Unit (Miltenyi Biotec, #008716) 
--- Auto MACS Running Buffer (MACS Separation Buffer, Miltenyi Biotec, cat# 
130-091-221). 
 
Procedure: 
Keep MACS buffer cold (on ice), but perform the rest of procedure at RT except when 
indicated. 
I. Preparation for the kill 
1. Prepare media/tubes 
a. Fill conical tubes with 3 mL MACS buffer. 
b. Prepare scissors, forceps, 70% EtOH squeeze bottle, 5 mL syringes. 
II. Kill/Co-culture  
2. Isolate CD4+ T cells from spleens  
a. Sacrifice mice by CO2. 
b. Place mice on their right side so that the left side faces you. 
c. Apply alcohol to the abdomen area. 
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d. Grab the skin of the abdomen with forceps and make a small incision. 
e. Peel back the skin/fur with fingers to expose the membrane underneath. 
f. Grab the membrane with forceps and cut the membrane to expose the organs. 
g. Remove the spleen (dark red organ) with forceps. 
h. Carefully remove as much fat from the exterior of the spleen as possible. 
i. Place a spleen in a 15 mL conical tube containing 3 mL MACS buffer, 
transfer to cell culture room. 
III. Single cell suspension** (Critical!!) Perform the following steps under sterile 
hood. 
1. Place the 70 µm Cell Strainer inside a 100mm petri dish, add 5 mL MACS buffer 
to wet the membrane. 
2. Transfer the spleen with the 3 mL MACS buffer onto the cell Strainer. 
3. Use a plunger from 5 mL syringe to mesh (by gently push, not grinding) the 
tissue inside the petri dish (Keep the tissue pieces wet at all time), till only 
connective tissue left on the membrane. 
4. Remove the cell strainer; transfer the 8 ml buffer (containing cells) into the 
original 15 mL conical tube.  Rinse the cell strainer inside dish with ~ 5 mL of 
MACS buffer; combine with the original 8 mL buffer in the conical tube, to get 
all the cells. 
5. Centrifuge the cell suspension at 300 x g for 10 min. 
6. Aspirate the supernatant (by attached a plastic pipet tip on top of glass pipet to 
reduce the suction force). 
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7. Tap the bottom of tube to break the pellet and get a better suspension. 
8. Add 8 mL MACS buffer to fully resuspend the cell pellet. 
9. Place a 30 µm MACS Pre-separation Filter on top of a 15 mL conical tube.  Add 
2 mL buffer to wet the filter.  Transfer the 8 mL cell suspension onto the filter; 
add small volume at a time, slowly, to prevent clogging too fast.  (Some 
connective tissues will remain on the filter membrane) 
10. Remove the filter, close the lid.  Gently invert the tube to get a good mixture.  
Transfer a small aliquot (~ 20 µL) of cell suspension to an epi-tube for 
counting*. 
11. Centrifuge the remaining cell suspension at 300 x g for 10 min. 
12. *While waiting for centrifugation, count cell number in a hemacytometer with 
(1) Trypan Blue (10 µL cell + 80 µL PBS + 10 µL Trypan Blue) to assess 
percent dead cells and; with (2) Crystal Violet stain (10 µL cells + 90 µL Crystal 
Violet) to assess WBC #.  (RBC will be lysed and nuclei of leukocytes will be 
stained blue
13. Or, just count the cell number by Coulter counter (set at 4 µm cut off) 
 (may need to adjust the focus to see the blue stain).  <Some time, 
you may need to dilute the original cell suspension before adding Trypan Blue or 
Crystal Violet.>  (The cell number obtained from Trypan Blue and Crystal Violet 
normally is pretty close, you don’t really need the crystal violet stain…) 
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IV. CD4+ T cell isolation 
1. Aspirate the supernatant (by attached a plastic pipet tip on top of glass pipet to 
reduce the suction force).  Tap the bottom of tube to break the pellet and get a 
better suspension, then resuspend cells in appropriate amount of MACS buffer 
required in 15 mL conical tube (90 µL cold MACS Buffer per 107 total cells** 
(should be primary WBC)
2. Add 
) for labeling with MACS microbeads.  (Load up to ~ 
40 x 106 WBC/MS column, too much will clog the column) Record starting cell 
numbers for calculating yield later… 
10 µL of CD4 (L3T4) Microbeads per 107 total cells
3. Mix well by pipetting, and incubate for exactly 15 min at 4°C (refrigerator, not 
ice!!) (No shaking needed) 
.  Make sure to add the 
microbead directly into the cells; don’t just add to the side of the tube. 
4. Wash cells by adding 1-2 mL of cold MACS buffer per 107 cells (10 – 20 fold of 
cell suspension volume), or, just fill
5. Aspirate the supernatant (by attached a plastic pipet tip on top of glass pipet to 
reduce the suction force), tap the bottom of tube to break the pellet and get a 
better suspension.  Resuspend in up to 500 µL cold MACS buffer per 108 cells.  
 the tube with MACS buffer; mix by 
inversion and centrifuge at 300 x g for 10 min.   
6. Place MS column at Octo MACS Separator (the separator should be adhering to 
the stand on the vertical side).   Orient the stick-outside of column against 
separator.  Put a basin under the column for collecting waste. 
7.  
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8. Prepare the following buffer volume is for MS column only. 
a. Rinse MS column with 500 µL cold MACS buffer.  Let the buffer slowly 
drip to dry itself.  (Very quick, less than 1 min, and it won’t really dry 
completely) 
b. Apply cell suspension onto the column.  
c. Let the unlabeled cells pass through.  Add 1.5 mL of cold MACS buffer 
to the sample tube (rinse to get all the cells), and wash MS column using 
the buffer inside the sample tube (3 times with 500 µL each, let the 
reservoir empty between each wash). => The effluent is the unlabelled 
fraction, does not contain CD4+ T cells)  
d. Remove MS column from the separator, and place it onto a collection 15 
mL conical tube. 
e. Pipette 1 mL of cold MACS buffer onto the column.  Immediately flush 
out fraction with the magnetically labeled cells by firmly applying the 
plunger supplied with the column.  Push the plunger into the column all 
the way, it will generate lots bubbles.   
f. Centrifuge the elution (containing labeled cells) at 300 x g for 10 min.  
Resuspend the cell pellet in complete medium. => CD4+ population.  
g. Count cell # with Trypan blue (for viability) or Coulter counter. 
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A-6. Purity of CD4+ T cells isolated using Miltenyi system 
 
CD4+ T cell purity (C57BL/6, analyzed by BD FACSCalibur) 
  
CD4+ T cell purity = 91.97 ± 1.05 % (n=3) 
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A-7. Comparison of cell count by hemocytometer and Coulter counter  
 
 
 
Objective: To test if Coulter counter can be used for T cell quantification. 
Methods: Purified CD4+ T cells by Miltenyi beads were resuspended in 1mL medium. 
Cells were subsequently counted by either Trypan Blue exclusion method or Coulter 
counter. 
Results: The cell numbers counted by the two different methods correlate at R2=0.9894. 
I concluded that Coulter counter can be used to count CD4+ T cells. 
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A-8. Counting Cells with Coulter Counter 
 
Prepare the vials with solution for counting the previous day and check the functioning 
of the counter 
1. Turn power on, open door, lower stage. 
2. Remove vial of Coulter Clenz, replace with Isotone/Isoflow, raise stage 
3. Readout:   Setup #1 (S1).   Scroll down to last line and set cell size.  This 
measurement is to be set for the smallest cell of acceptable range.  For CD4+ 
cells, it is 4 µm.   
4. Select: FUNCTIONS on keypad.   Scroll to flush aperture.   Hit: START/STOP 
to flush.  Repeat flush, and then replace Isotone.   Flush twice more. 
5. Select: OUTPUT on keypad.  Scroll to Count / Concentration and select one.  If 
“concentration” is selected, readout will be in #cells/ml.  Scroll to Dilution and 
enter dilution factor.   Leave units on um. 
6. Prepare sample cups 24-48 hours ahead:   De-gas Isotone by turning red lever to 
the left.   Lift dispensing pump twice.   Turn red lever so it is parallel to the arm.  
Fill Coulter vials with 20 ml per vial (two pumps of Isotone). 
7. Add 40 µl sample to Coulter vial (for 1:500 dil).  Place vial on stage, raise, and 
press START/STOP on keypad to count.   Count each sample 2-3 times and 
average. 
8. To shut down machine, replace vial of blue Coulter Clenz and flush aperture 
(under FUNCTIONS) 2-3 times.   When flush is complete, turn off power.  
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A-9. Counting Cells with Hemacytometer 
A. Materials: 
i) Trypan blue (Sigma, cat# T8154). 
ii) Eppendorf tubes. 
iii) Hemacytometer. 
B. Methods: 
i) Add 180 µL H2O and 10 µL Trypan blue to an epi-tube. 
ii) Mix the T cells and remove 10 µL to add to a sample tube with Trypan 
blue. 
iii) Mix by pipetting up and down several times. 
iv) Remove about 20 µL from the suspension and put in a hemacytometer. 
v) Count the viable white cells by microscope at 10x magnification (count at 
200 cells at least) 
                Cell concentration (cells/mL) = (cell count)/ (squares) × 104  × 20 
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A-10. Hybridoma Handling (145-2C11, UC8-1B9) 
I. Reagents 
1. Complete medium 
 Vol(mL) % Stock Conc 
Final 
Conc 
Vendor Cat# 
DMEM, high 
glucose formula 
500.00  86.03   Gibco 11960-44 
HI-FBS 58.00  9.98   
Irvine 
Scientific 
30032043
9 
Glutamax 11.60  2.00  200mM 4mM Gibco 
35050-
061 
Na pyruvate (in 
cold room) 
5.80  1.00  100mM 1mM Cellgro 25-000-CI 
Pen-Strep 5.80  1.00  
10,000 
U/mL P 
10,000 
ug/mL S 
100 
U/mL 
P 
100 
ug/mL 
S 
Gibco 
15140-
148 
Total 581.20  100.00     
 
2. Cryoprotectant medium: complete medium with 5% (v/v) sterile DMSO 
3. hIL-6: During critical period (ie. After thawing from our lab depository in the N2 
tank), add 80u/ml hIL-6. hIL-6 stock is 200,000U/ml. Aliquots stored at -20 deg 
C. Eg: Mix 50ml complete media with 20ul hIL-6 (stock). (Roche, Cat# 11-138-
600-001, Lot# 93320322).  
4. Cell-line 
 145-2C11: ATCC Cat# CRL-1975 (Mouse anti-CD3 expressing hybridoma) 
 UC8-1B9: ATCC Cat# CRL-1968 (Mouse anti-DNP expressing hybridoma) 
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5. Handling frozen cells from ATCC 
a. For the 1st culture after purchase, Take 10 mL of complete media in 15 mL 
falcon tube. 
b. Fill one T-75 flask with complete medium (the volumes differ to each batch. 
Confirm to Specific Batch Info) 
c. For culturing cells from our own frozen cells (2x106 cells in 2 mL 
cryoprotective medium kept in liquid N2 tank), prepare 18 mL complete 
media in T-75 flask. 
d. Place the flask into 5% CO2 incubator at 37oC for at least 15min. 
e. Thaw the vial by gentle agitation in a 37 oC water bath. To reduce the 
possibility of contamination, keep the O-ring and cap out of the water. 
Thawing should be rapid (approx. 2 min). 
f. Move the vial to sterile hood, and spray 70% EtOH to the vial. 
g. Transfer the thawed cell suspension into the 15 ml falcon tube prepared in 
step 1. 
h. Spin down (100x g, 5 min, critical) and aspirate supernatant to remove 
cryoprotective DMSO. 
i. Resuspend cells in 2 mL complete media. 
j. Transfer the cells to the pre-warmed T-75 flask prepared at step 3 or 4. 
k. Incubate in 5% CO2 incubator at 37 oC. 
l. After thawing, cells become confluent in 3- 4 days.  
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m. After 1st media change, cells become confluent and need to be passed every 
2-3 d (If media look yellow-it means acidic-, pass cells immediately). 
n. Count cell concentration by Coulter Counter. Adjust concentration to 1x106 
cells/mL (for experiments) by adding complete DMEM media. 
o. Generally, Raje used cells between 5rd to 12th passages for her 
immunofluorescence experiments. 
6. Handling frozen cells from our lab N2 Tank storage 
a. Prepare 18 mL complete media by adding 8 ul of hIL-6 in a T-75 flask and 
keep the flask in the 37oC incubator for ~15 min. 
b. Take 10 mL of complete media in 15 mL falcon tube. 
c. Thaw the vial by gentle agitation in a 37 oC water bath. To reduce the 
possibility of contamination, keep the O-ring and cap out of the water. 
Thawing should be rapid (approx. 2 min). 
d. Move the vial to sterile hood, and spray 70% EtOH to the vial. 
e. Transfer the thawed cell suspension into the 15 ml falcon tube prepared in 
step 2. 
f. Spin down (100x g, 5 min, critical) and aspirate supernatant to remove 
cryoprotective DMSO. 
g. Resuspend cells in 2 mL complete media. 
h. Transfer the cells to the pre-warmed T-75 flask prepared at step 1. 
i. Incubate in 5% CO2 incubator at 37 oC. 
j. After thawing, cells become confluent in 3- 4 days.  
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  Note: Media change from now on will be in complete media; no hrIL-6; 
  cells become confluent and need to be passed every 2-3 days (If media 
  looks  yellow-it means acidic-, pass cells immediately). 
k. Count cell concentration by Coulter Counter. Adjust conc. to 1x106 cells/mL 
(for experiments) by   adding complete DMEM media. 
7. Freezing cells to our lab N2 Tank storage 
a. Prepare 18 mL complete media in a T-75 flask and keep the flask in the 37oC 
incubator for ~15 min. 
b. Harvest suspending cells by pipette into a 50 mL conical tube. (Try to avoid 
mixing adherent cells by shaking flask or touching the flask bottom).  
c. (Optional) If you need to keep cells in liquid N2 tank for future study, take 
~half volume of cell suspension into a separate 50 mL conical tube for 
freezing and the other half for future passages. Label the two falcon tubes.( 
Tube 1: Freezing, Tube 2: Passage). 
d. Take 10-20 ul for cell concentration by Coulter Counter (4 um).  
e. Centrifuge cells at 300x g for 5 min. (50 ml falcon tube from step 3) 
f. Aspirate the supernatant and resuspend cells; adjusting the conc. to 1x106 
cells/mL by adding complete DMEM with 5% sterile DMSO 
g. Aliquot 1 mL cell suspension containing 5% DMSO into 2.5 mL cryotubes, 
and label on tubes cell type, date, passage number, cell number and your 
initial. Freeze in a “Mr. Frosty” at -80oC overnight. Next day, move to liquid 
N2 tank. 
65 
 
<For further passage > 
h. Transfer 2 mL cell suspension from the falcon tube 2; prepared and 
centrifuged in step 3-5; into the pre-warmed T-75 flask in step 1 of freezing 
cells. 
i. Place the flask in the 37oC 5% CO2 incubator. 
<Cell viability of adherent cells> 
j. (For 145-2C11 and UC8-1B9) A number of cells are adherent to the flask 
bottom. The viability of 145-2C11 was 93.66% (suspending cells) and 
77.77% (adherent cells) determined by trypan blue exclusion method. 
Therefore, use only suspending cells by pipetting up the media, not touching 
the flask bottom. 
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A-11. Experiment Plan 
  
 
Coating two slides with Poly-L-lysine for 30 min. 
 
   
   
Slide 1. Slide 2.  
  
                  Chamber 1.      Chamber 2.           Chamber 3.   Chamber 4.  
                       
Isolate CD+ T cells 
 
                                                                                     
 
  
 
 
      
 
 
 
 
 
 
 
 
 
At the Vet. School in Dr. Burghardt’s Lab: 
 
Hybridoma Cells(Vet school culture) 
 
 
 
 
1. Prepare the calcium dye 
2. Labeling T-cells with calcium dyes 
3. Mix T-cell with Hybridoma(5:1) 
4. Rinse the slides with 1ml Lebovitz’s medium. 
5. Transfer 1.2 ml cell suspension to chamber of different slides. 
6. Image: Capture images after 15 min. incubation in 37 deg.C. 5%CO2.  
 
Report time of the image taken and copy images on pen drive and bring to Kleberg Lab 
323 for analysis. 
 
 
 
1:10 dil; 1.5 ml   1:10 dil; 1.5 ml 
    
1:10dil; 1.5 ml 1:10dil;1.5 ml 
Fat-1mouse 
Kill / Spleens 
Single cell suspension 
CD4+ T-cells 
 
- Miltenyi® column 
~18 to 20x106 cells 
Resuspend or dilute 
cells to have  
2x106 cells/ml 
 
At Kleberg 
2x106 cells/ml; in Lebowitz media containing 5% 
normal FBS. 
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A-12. Diagrammatic representation of the Experimental Protocol 
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A-13. Mitochondria Imaging in T cells 
  
I. Preparation of poly-L-lysine (Sigma, cat#P8920)) coated chamber slides (Lab-
tech chambered cover glass slides, 31 German Borosilicate, Nunc, and Cat 
#155380). 2 slides (4 chambers) 
1. Dilute 1ml poly-L-lysine in 9 ml sterile water. 
2. Dispense 1.5 ml of diluted poly-L-lysine into each well of 2 slides (4 chambers) 
3. Incubate for 30 minutes at RT.(leave in the hood and label: Do not move) 
4.  Aspirate the solution and wash with 1 ml warm Leibovitz before using  
II. Isolate CD4+ T cells from spleens of WT/ fat-1 mice  
1. CD4+ T-cells at 2 million cells /ml/tube in RPMI media, incubate at 37°C with 
5% CO2 (*Loosen the caps of the tubes when in the incubator)  
2. Hybridoma (CD3+) at 2 million cells/ml – (*Cells in phenol free complete 
DMEM media)  
3. Mitochondrial dyes  
4. Leibovitz’s medium  
5. 10p pipette/tips 
6. 200p pipette/tips 
7. 1000p pipette/tips 
8. Timer 
9. Poly-L-Lysine coated chamber slides 
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III. Dye Preparation 
1. Prepare stock solutions of MitoTracker Green FM on the day of experiment  
  Stock preparation of 1 mM Mitotracker Green FM, Molecular 
 Probes, M-7514 
a. Molecular weight of Mitotracker is 671.88 and the vial contains 
50 µg. 
b. Dissolve 50 µg Mitotracker (vial) in 74.42 µl DMSO to make up 
1 mM Mitotracker 
c. Mix well by pipetting up and down. 
d. 0.2 µl of Mitotracker green stock needs to be added to the 1ml of 
Leibovitz media for incubation to make a final concentration of 
200 nM. 
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A-14. T cell labeling Mitochondrial localization 
 
I. Labeling of Mitotracker for mitochondrial translocation  
1. Add 0.2 uL of [1 mM stock] Mitotracker solution into 1ml CD4+ T cell 
suspension. 
2. Vortex for 2 sec. Keep the lid of the tube loose. 
3. Incubate at 37 deg.C. for 10 min. 
4. Spin down at the speed 5 (Dr. Burghardt’s centrifuge) for 5 min. 
5. Suck out dye with the media. 
6. Resuspend cells in 1 ml Leibovitz’s medium. 
II. Mix cells (T cell:hybridoma = 5:1) 
1. Mix 0.2 mL hybridoma into 1ml T cell suspension. 
2. Transfer 1.2 mL of cell suspension from the tube to 1 well of the chambered 
slide. 
3. Visualize and see the best synapse.  Capture images starting at “0” time after 
mixing with hybridoma cells and continue on for 30 min (1 image every 3 
minutes for time kinetic). 
4. Collect your images, report time after the experiment and bring to lab 323 in 
Kleberg. The images are analyzed using adobe photoshop on our 323 lab 
computer. 
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A-15. Measurement of Mitochondrial Ca2+ in T cells  
 
I. Preparation of poly-L-lysine (Sigma, cat#P8920)) coated chamber slides 
(Lab-tech chambered cover glass slides, 31 German Borosilicate, Nunc, and 
Cat #155380). 2 slides (4 chambers) 
1. Dilute 1ml poly-L-lysine in 9 ml sterile water. 
2. Dispense 1.5 ml of diluted poly-L-lysine into each well of 2 
slides (4 chambers) 
3. Incubate for 30 minutes at RT.(leave in the hood and label: Do 
not move) 
4. Aspirate the solution and wash with 1 ml warm Leibovitz before 
using  
II. Isolate CD4+ T cells from spleens of WT/ fat-1 mice  
1. CD4+ T-cells at 2 million cells /ml/tube in RPMI media, incubate at 37°C 
with 5% CO2 (*Loosen the caps of the tubes when in the       incubator)  
2. Hybridoma (CD3+) at 2 million cells/ml – (*Cells in phenol free complete 
DMEM media)  
3. Mitochondrial dyes  
4. Leibovitz’s medium  
5. 10p pipette/tips 
6. 200p pipette/tips 
7. 1000p pipette/tips 
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8. Timer 
9. Poly-L-Lysine coated chamber slides 
III. Dye Preparation 
1. Prepare stock solutions on the day of experiment  
  Stock preparation of 1 mM Mitotracker Green FM, Molecular 
 Probes, M-7514 
a. Molecular weight of Mitotracker is 671.88 and the vial 
contains 50 µg. 
b. Dissolve 50 µg Mitotracker (vial) in 74.42 µl DMSO to make 
up 1 mM Mitotracker 
c. Mix well by pipetting up and down. 
d. 0.2 µl of Mitotracker green stock needs to be added to the 
1ml of Leibovitz media for incubation to make a final 
concentration of 200 nM. 
 Stock preparation of 4 mM stock of Rhod-2, Molecular Probes, 
 R1245 
a. Molecular weight of Rhod-2 is 1123.96 and the vial contains 50 µg. 
b. Dissolve 50 µg of Rhod-2 (vial) in 10 µl DMSO to make up 5 mM Rhod-
2 
c. Mix well by pipetting up and down. 
d. 0.3 µl of Rhod-2 stock needs to be added to 1 ml Leibovitz media to make 
a final concentration of 1.5 µM 
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IV. T cell labeling Mitochondrial  Ca2+ measurement 
1. Labeling of Mitotracker, and Rhod-2 for mitochondrial Ca2+  
a. Add 0.5 uL of [5 mM stock] Rhod-2 into 1ml CD4+ T cell 
suspension. 
b. Vortex for 2 sec. 
c. Incubate at 37 deg.C. for 15 min. 
d. Add 0.2 uL of [1 mM stock] Mitotracker solution into 1ml 
CD4+ T cell suspension. 
e. Vortex for 2 sec. Keep the lid of the tube loose. 
f. Incubate at 37 deg.C. for 15 min. 
g. Spin down at the speed 5 (Dr. Burghardt’s centrifuge) for 5 
min. 
h. Suck out dye with the media. 
i. Resuspend cells in 1 ml Leibovitz’s medium. 
2. Mix cells (T cell:hybridoma = 5:1) 
a. Mix 0.2 mL hybridoma into 1ml T cell suspension. 
b. Transfer 1.2 mL of cell suspension from the tube to 1 well of 
the chambered slide. 
c. Visualize and see the best synapse.  Capture images.  
d. Collect your images, report time after the experiment and 
bring to lab 323 in Kleberg. The images are analyzed using 
adobe photoshop on our 323 lab computer. 
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A-16. Measurement of mitochondrial-to-cytosolic Ca2+ ratio using Rhod-2 and 
Fluo-4  
I. Preparation of poly-L-lysine (Sigma, cat#P8920)) coated 
chamber slides (Lab-tech chambered cover glass slides, 31 
German Borosilicate, Nunc, and Cat #155380). 2 slides (4 
chambers) 
1. Dilute 1ml poly-L-lysine in 9 ml sterile water. 
2. Dispense 1.5 ml of diluted poly-L-lysine into each well of 2 
slides (4 chambers) 
3. Incubate for 30 minutes at RT.(leave in the hood and label: Do 
not move) 
4.  Aspirate the solution and wash with 1 ml warm Leibovitz 
before using  
II. Isolate CD4+ T cells from spleens of WT/ fat-1 mice  
1. CD4+ T-cells at 2 million cells /ml/tube in RPMI media, incubate at 37°C 
with 5% CO2 (*Loosen the caps of the tubes when in the incubator)  
2. Hybridoma (CD3+) at 2 million cells/ml – (*Cells in phenol free complete 
DMEM media)  
3. Mitochondrial dyes  
4. Leibovitz’s medium  
5. 10p pipette/tips 
6. 200p pipette/tips 
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7. 1000p pipette/tips 
8. Timer 
9. Poly-L-Lysine coated chamber slides 
III. Dye Preparation 
1. Prepare stock solutions on the day of experiment  
 Stock preparation of 4 mM stock of Rhod-2, Molecular Probes,  
 R1245 
a. Molecular weight of Rhod-2 is 1123.96 and the vial contains 
50 µg. 
b. Dissolve 50 µg of Rhod-2 (vial) in 10 µl DMSO to make up 
5 mM Rhod-2 
c. Mix well by pipetting up and down. 
d. 0.3 µl of Rhod-2 stock needs to be added to 1 ml Leibovitz 
media to make a final concentration of 1.5 µM 
 Stock preparation of 2 mM stock of Fluo-4, Molecular Probes, 
 F14201 
a. Molecular weight of Fluo-4 is 1096.95 and the vial contains 
50 µg. 
b. Dissolve 50 µg of Fluo-4 (vial) in 25 µl DMSO to make up 2 
mM Fluo-4 
c. Mix well by pipetting up and down. 
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d. 1.5 µl of Fluo-4 stock needs to be added to 1 ml Leibovitz 
media to make a final concentration of 3 µM 
IV. T cell labeling Mitochondrial  and Cytosolic Ca2+   
1. Labeling of Rhod-2, and Fluo-4 for mitochondrial and Cytosolic Ca2+  
a. Add 0.5 ul of [3 mM stock] Fluo-4 solution into 1ml CD4+ T 
cell suspension. 
b. Vortex for 2 sec. 
c. Incubate at 37 deg.C. for 30 min. 
d. Add 0.3 ul of [5 mM stock] Rhod-2 solution into 1ml CD4+ 
T cell suspension. 
e. Incubate at 37 deg.C. for 30 min. 
f. Spin down at the speed 5 (Dr. Burghardt’s centrifuge) for 5 
min. 
g. Resuspend cells in 1 ml Leibovitz’s medium. 
h. Incubate at 37 deg.C. for 15 min. 
i. Spin down at the speed 5(Dr. Burghardt’s centrifuge) for 5 
min. 
j. Resuspend cells in 1 ml Leibovitz’s medium. 
2. Mix cells (T cell:hybridoma = 5:1) 
a. Mix 0.2 mL hybridoma into 1ml T cell suspension. 
b. Transfer 1.2 mL of cell suspension from the tube to 1 well of 
the chambered slide. 
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c. Visualize and see the best synapse.  Capture images.  
d. Collect your images, report time after the experiment and 
bring to lab 323 in Kleberg. The images are analyzed using 
adobe photoshop on our 323 lab computer. 
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A-17. Measurement of mitochondrial-to-cytosolic Ca2+ ratio by blocking 
mitochondrial uniporter using RU-360 
 
I. Preparation of poly-L-lysine (Sigma, cat#P8920)) coated chamber slides 
(Lab-tech chambered cover glass slides, 31 German Borosilicate, Nunc, and 
Cat #155380). 2 slides (4 chambers) 
1. Dilute 1ml poly-L-lysine in 9 ml sterile water. 
2. Dispense 1.5 ml of diluted poly-L-lysine into each well of 2 
slides (4 chambers) 
3. Incubate for 30 minutes at RT.(leave in the hood and label: Do 
not move) 
4.  Aspirate the solution and wash with 1 ml warm Leibovitz 
before using  
II. Isolate CD4+ T cells from spleens of WT/ fat-1 mice  
1. CD4+ T-cells at 2 million cells /ml/tube in RPMI media, incubate at 37°C 
with 5% CO2 (*Loosen the caps of the tubes when in the incubator)  
2. Hybridoma (CD3+) at 2 million cells/ml – (*Cells in phenol free complete 
DMEM media)  
3. Mitochondrial dyes  
4. Leibovitz’s medium  
5. 10p pipette/tips 
6. 200p pipette/tips 
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7. 1000p pipette/tips 
8. Timer 
9. Poly-L-Lysine coated chamber slides 
III. Dye Preparation 
1. Prepare stock solutions on the day of experiment  
  Stock preparation of 4 mM stock of Rhod-2, Molecular Probes, 
 R1245 
a. Molecular weight of Rhod-2 is 1123.96 and the vial contains 
50 µg. 
b. Dissolve 50 µg of Rhod-2 (vial) in 10 µl DMSO to make up 
5 mM Rhod-2 
c. Mix well by pipetting up and down. 
d. 0.3 µl of Rhod-2 stock needs to be added to 1 ml Leibovitz 
media to make a final concentration of 1.5 µM 
 Stock preparation of 2 mM stock of Fluo-4, Molecular Probes, 
 F14201 
a. Molecular weight of Fluo-4 is 1096.95 and the vial contains 
50 µg. 
b. Dissolve 50 µg of Fluo-4 (vial) in 25 µl DMSO to make up 2 
mM Fluo-4 
c. Mix well by pipetting up and down. 
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a. µl of Fluo-4 stock needs to be added to 1 ml Leibovitz media 
to make a final concentration of 3 µM 
 Stock preparation of 10mM stock of RU-360, Calbiochem, 557440 
a. Take ~ 5 ml nanopure water in a 15 ml falcon and blow nitrogen from the 
nitrogen tank using a clean new glass pipette for 10 min. 
b. Flush the lid with Nitrogen and tightly close the falcon tube and rush to 
the hood of cell culture and add the water into the vial of RU-360 and mix 
well 
c. Molecular weight of RU-360 is 550.8 and the vial contains 
100 µg. 
d. Dissolve 100 µg of RU-360 (vial) in 181.6 µl degassed 
nanopure water to make up 10 mM RU-360 
e. Mix well by pipetting up and down gently without 
introducing any air bubbles.  
f. 1.0 µl of RU-360 stock needs to be added to 1 ml Leibovitz 
media to make a final concentration of 10 µM 
 
IV. T cell labeling Mitochondrial  and Cytosolic Ca2+ and mitochondria 
uniporter inhibitor   
1. Incubation with RU-360 and labeling ofRhod-2, and Fluo-4 for mitochondrial 
and Cytosolic Ca2+  
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a. Add 1.0 ul of [10 mM stock] RU-360 solution into 1ml CD4+ 
T cell suspension. 
b. Vortex for 2 sec. 
c. Incubate at 37 deg.C. for 30 min. 
d. Spin down at the speed 5 (Dr. Burghardt’s centrifuge) for 5 
min. 
e. Resuspend cells in 1 ml Leibovitz’s medium. 
f. Add 0.5 ul of [3 mM stock] Fluo-4 solution into 1ml CD4+ T 
cell suspension. 
g. Vortex for 2 sec. 
h. Incubate at 37 deg.C. for 30 min. 
i. Add 0.3 ul of [5 mM stock] Rhod-2 solution into 1ml CD4+ 
T cell suspension. 
j. Incubate at 37 deg.C. for 30 min. 
k. Spin down at the speed 5 (Dr. Burghardt’s centrifuge) for 5 
min. 
l. Resuspend cells in 1 ml Leibovitz’s medium. 
m. Incubate at 37 deg.C. for 15 min. 
n. Spin down at the speed 5(Dr. Burghardt’s centrifuge) for 5 
min. 
o. Resuspend cells in 1 ml Leibovitz’s medium. 
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2. Mix cells (T cell:hybridoma = 5:1) 
a. Mix 0.2 mL hybridoma into 1ml T cell suspension. 
b. Transfer 1.2 mL of cell suspension from the tube to 1 
well of the chambered slide. 
c. Visualize and see the best synapse.  Capture images.  
d. Collect your images, report time after the experiment and 
bring to lab 323 in Kleberg. The images are analyzed 
using adobe photoshop on our 323 lab computer. 
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A-18. Measurement of mitochondrial-to-cytosolic Ca2+ ratio by blocking CRAC 
channel using BTP-2 
 
I. Preparation of poly-L-lysine (Sigma, cat#P8920)) coated chamber slides 
(Lab-tech chambered cover glass slides, 31 German Borosilicate, Nunc, and 
Cat #155380). 2 slides (4 chambers) 
1. Dilute 1ml poly-L-lysine in 9 ml sterile water. 
2. Dispense 1.5 ml of diluted poly-L-lysine into each well of 2 slides (4 
chambers) 
3. Incubate for 30 minutes at RT.(leave in the hood and label: Do not move) 
4.  Aspirate the solution and wash with 1 ml warm Leibovitz before using  
II. Isolate CD4+ T cells from spleens of WT/ fat-1 mice  
1. CD4+ T-cells at 2 million cells /ml/tube in RPMI media, incubate at 37°C 
with 5% CO2 (*Loosen the caps of the tubes when in the incubator)  
2. Hybridoma (CD3+) at 2 million cells/ml – (*Cells in phenol free complete 
DMEM media)  
3. Mitochondrial dyes  
4. Leibovitz’s medium  
5. 10p pipette/tips 
6. 200p pipette/tips 
7. 1000p pipette/tips 
8. Timer 
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9. Poly-L-Lysine coated chamber slides 
III. Dye Preparation 
1. Prepare stock solutions on the day of experiment  
  Stock preparation of 4 mM stock of Rhod-2, Molecular Probes, 
 R1245 
a. Molecular weight of Rhod-2 is 1123.96 and the vial contains 
50 µg. 
b. Dissolve 50 µg of Rhod-2 (vial) in 10 µl DMSO to make up 
5 mM Rhod-2 
c. Mix well by pipetting up and down. 
d. 0.3 µl of Rhod-2 stock needs to be added to 1 ml Leibovitz 
media to make a final concentration of 1.5 µM 
 Stock preparation of 2 mM stock of Fluo-4, Molecular Probes, 
 F14201 
a. Molecular weight of Fluo-4 is 1096.95 and the vial contains 
50 µg. 
b. Dissolve 50 µg of Fluo-4 (vial) in 25 µl DMSO to make up 2 
mM Fluo-4 
c. Mix well by pipetting up and down. 
d. 1.5 µl of Fluo-4 stock needs to be added to 1 ml Leibovitz 
media to make a final concentration of 3 µM 
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 Stock preparation of 100µM stock of BTP-2, Calbiochem, 203890 
a. Molecular weight of BTP-2 is 421.3 and the vial contains 
5mg. 
b. Dissolve 5 mg of BTP-2 (vial) in 1.1868 µl of DMSO to 
make up 10 mM BTP-2. Take 10µl of 10 mM BTP-2 and add 
1mL of DMSO to make 100 µM of BTP-2 working stock.  
c. Mix well by pipetting up and down gently without 
introducing any air bubbles. 
d. 1 µl of BTP-2 working stock needs to be added to 1 ml 
Leibovitz media to make a final concentration of 10 µM 
IV. T cell labeling Mitochondrial  and Cytosolic Ca2+ and CRAC channel 
inhibitor   
1. Incubation with BTP-2 and labeling ofRhod-2, and Fluo-4 for mitochondrial 
and Cytosolic Ca2+  
a. Add 1.0 ul of [100 µM stock] BTP-2 solution into 1ml CD4+ 
T cell suspension. 
b. Vortex for 2 sec. 
c. Incubate at 37 deg.C. for 1 hr. 
d. Spin down at the speed 5 (Dr. Burghardt’s centrifuge) for 5 
min. 
e. Resuspend cells in 1 ml Leibovitz’s medium. 
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f. Add 0.5 ul of [3 mM stock] Fluo-4 solution into 1ml CD4+ T 
cell suspension. 
g. Vortex for 2 sec. 
h. Incubate at 37 deg.C. for 30 min. 
i. Add 0.3 ul of [5 mM stock] Rhod-2 solution into 1ml CD4+ 
T cell suspension. 
j. Incubate at 37 deg.C. for 30 min. 
k. Spin down at the speed 5 (Dr. Burghardt’s centrifuge) for 5 
min. 
l. Resuspend cells in 1 ml Leibovitz’s medium. 
m. Incubate at 37 deg.C. for 15 min. 
n. Spin down at the speed 5(Dr. Burghardt’s centrifuge) for 5 
min. 
o. Resuspend cells in 1 ml Leibovitz’s medium. 
2. Mix cells (T cell:hybridoma = 5:1) 
a. Mix 0.2 mL hybridoma into 1ml T cell suspension. 
b. Transfer 1.2 mL of cell suspension from the tube to 1 well of 
the chambered slide. 
c. Visualize and see the best synapse.  Capture images.  
d. Collect your images, report time after the experiment and 
bring to lab 323 in Kleberg. The images are analyzed using 
adobe photoshop on our 323 lab computer. 
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A-19. Calculation of Intensity at Region of Interest 
 
1. Capture images and convert the image files to 8-bit TIFF format, using save as 
option on the zeiss image viewer software. 
2. Open the image file in Adobe Photoshop® CS (v.8.0). 
3. Using a marquee tool, make a circle to select cell-cell contact region.  
4. In “Histogram” panel, we can choose each channel of RGB. 
5. Once blue channel is selected, the panel displays “mean intensity” of marquee-
selected region. 
6. Histogram also shows the pixels chosen by marquee tool. We generally choose 
800-1200 pixels for contact region. 
7. If you change the channel to green, mean intensity is changed, while pixel is not. 
8. For non-contact control cells, select whole cell by marquee tool. 
9. Histogram shows green/blue mean intensities. 
10. Record the intensity for green and red channel. 
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